AUTHOR NAME
LINDA PEARSON
65 POSTS
0 COMMENTS
KOSÉ Earns ESG Recognition Across Major Indexes for 2025
KOSÉ ESG recognition control is confirmed until 2025, with the company to achieve four main stability and location in the regime index. Kosé Corporation...
Axe Launches Fragrance-Led Strategy to Win Gen Z Consumers
The Axe Gen Z fragrance strategy is reshaping how the brand connects with younger consumers through fine fragrance launches, humour-led marketing and social-first campaigns....
P&G’s Commitment to Net Zero Ambitions by 2040 News
P&G net zero commitment aims to eliminate greenhouse gas issues throughout the supply chain and operation by 2040. 2040. Retail Delivery. The company follows...
What’s Driving the Beauty Industry Shift in 2025
The cosmetics industry is adjusting to new pressures across every level of operation. From workforce restructuring to smart packaging and diagnostic technology, the sector...
LUXE PACK Monaco 2025 Redefines Packaging Innovation for the Cosmetics Industry
The cosmetics industry develops much faster than ever - and the way beauty brands approach packaging changes with it. The center for this shift...
LUXE PACK Monaco 2025 to Debut Immersive New Format
The Luxe Pack Monaco 2025 will introduce a reunited version of the global luxury packaging event organized from September 29 to October 1 at...
LVMH Reports €40 Billion Revenue in H1 2025 Amid Global Disruptions
Solid Results for LVMH that turnover of € 39.8 billion in the first half of 2025, showing strong flexibility despite the ongoing global geopolitical...
LVMH Launches New Employer Brand Campaign: “Where Dreams Become Careers”
LVMH has announced a new global employer brand campaign titled “Where Dreams Become Careers”, set to roll out starting September 30. The campaign supports...
P&G Champions Disability Confidence at 2025 Disability:IN Conference
Proctor & Gambles demonstrated their ongoing commitment to inclusive innovation in disability in 2025: At the Global Conference and Expo. As a current sponsor,...
European Commission Approves DARZALEX as First Treatment for High-Risk Smouldering Multiple Myeloma
The European Commission has granted marketing authorisation for DARZALEX® (daratumumab) as a monotherapy treatment for adults with high-risk smouldering multiple myeloma. This marks the...